LYMPHOPROLIFERATIVE DISORDER
Clinical trials for LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune drug trial offers hope for Tough-to-Treat Virus-Linked cancers
Disease control Recruiting nowThis study is testing the drug nivolumab to see if it can slow or stop the growth of certain cancers linked to the Epstein-Barr virus (EBV). It is for people aged 12 and older with EBV-positive lymphomas or lymphoproliferative disorders who have no standard therapy options or who…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New combo therapy aims to control lymphoma, possibly stop treatment after remission
Disease control Recruiting nowThis study is testing a two-drug combination (acalabrutinib and obinutuzumab) for people with untreated, slow-growing non-Hodgkin lymphomas. The goal is to see if this approach can effectively control the cancer, improve quality of life, and determine if patients who achieve a co…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Massive study aims to unlock future cures by tracking 75,000 young cancer patients
Knowledge-focused Recruiting nowThis study is creating a large registry and tissue bank for children and young adults with cancer. It collects health information and leftover tissue samples from patients up to age 25 to help researchers understand these diseases better. The goal is to use this information to im…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:27 UTC
-
Scientists gather clues from patients to unlock mysteries of blood cancers
Knowledge-focused Recruiting nowThis study is collecting and storing blood and tissue samples from patients with blood cancers like leukemia and lymphoma. The goal is to build a library of samples for researchers to study, which may help them better understand these diseases and develop new treatments in the fu…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC
-
Scientists hunt for genetic clues to dangerous CAR-T side effect
Knowledge-focused Recruiting nowThis study aims to understand why many patients develop low blood cell counts after receiving CAR-T therapy for certain blood cancers. Researchers will collect genetic and tissue samples from patients before and after treatment to look for inherited or acquired gene changes linke…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC